ArticleAmerican journal of ophthalmology case reports2025

High-dose topotecan (90 and 180 μG) for recurrent subretinal and vitreous seeding in retinoblastoma.

David H Abramson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.